159 related articles for article (PubMed ID: 6138246)
1. Somatostatin analogs: correlation between receptor binding affinity and biological potency in GH pituitary cells.
Schonbrunn A; Rorstad OP; Westendorf JM; Martin JB
Endocrinology; 1983 Nov; 113(5):1559-67. PubMed ID: 6138246
[TBL] [Abstract][Full Text] [Related]
2. Somatostatin analogs. Dissociation of brain receptor binding affinities and pituitary actions in the rat.
Srikant CB; Patel YC
Endocrinology; 1981 Jan; 108(1):341-3. PubMed ID: 6109622
[TBL] [Abstract][Full Text] [Related]
3. Novel heptapeptide somatostatin analog displays anti-tumor activity independent of effects on growth hormone secretion.
Murphy WA; Taylor JE; Moreau JP; Coy DH
Pept Res; 1989; 2(1):128-32. PubMed ID: 2577697
[TBL] [Abstract][Full Text] [Related]
4. Somatostatin receptors on pituitary somatotrophs, thyrotrophs, and lactotrophs: pharmacological evidence for loose coupling to adenylate cyclase.
Epelbaum J; Enjalbert A; Krantic S; Musset F; Bertrand P; Rasolonjanahary R; Shu C; Kordon C
Endocrinology; 1987 Dec; 121(6):2177-85. PubMed ID: 2890515
[TBL] [Abstract][Full Text] [Related]
5. Regulation of growth hormone and prolactin gene expression and secretion by chimeric somatostatin-dopamine molecules.
Gruszka A; Ren SG; Dong J; Culler MD; Melmed S
Endocrinology; 2007 Dec; 148(12):6107-14. PubMed ID: 17656461
[TBL] [Abstract][Full Text] [Related]
6. Somatostatin inhibits basal and vasoactive intestinal peptide-stimulated hormone release by different mechanisms in GH pituitary cells.
Dorflinger LJ; Schonbrunn A
Endocrinology; 1983 Nov; 113(5):1551-8. PubMed ID: 6138245
[TBL] [Abstract][Full Text] [Related]
7. Characterization of pituitary membrane receptors for somatostatin in the rat.
Srikant CB; Patel YC
Endocrinology; 1982 Jun; 110(6):2138-44. PubMed ID: 6122562
[TBL] [Abstract][Full Text] [Related]
8. Somatostatin inhibits vasoactive intestinal peptide-stimulated cyclic adenosine monophosphate accumulation in GH pituitary cells.
Dorflinger LJ; Schonbrunn A
Endocrinology; 1983 Nov; 113(5):1541-50. PubMed ID: 6194974
[TBL] [Abstract][Full Text] [Related]
9. Iodination of [Tyr11]somatostatin yields a super high affinity ligand for somatostatin receptors in GH4C1 pituitary cells.
Presky DH; Schonbrunn A
Mol Pharmacol; 1988 Nov; 34(5):651-8. PubMed ID: 2904115
[TBL] [Abstract][Full Text] [Related]
10. The novel somatostatin analog SOM230 is a potent inhibitor of hormone release by growth hormone- and prolactin-secreting pituitary adenomas in vitro.
Hofland LJ; van der Hoek J; van Koetsveld PM; de Herder WW; Waaijers M; Sprij-Mooij D; Bruns C; Weckbecker G; Feelders R; van der Lely AJ; Beckers A; Lamberts SW
J Clin Endocrinol Metab; 2004 Apr; 89(4):1577-85. PubMed ID: 15070915
[TBL] [Abstract][Full Text] [Related]
11. Cloned somatostatin receptors: identification of subtype-selective peptides and demonstration of high affinity binding of linear peptides.
Raynor K; Murphy WA; Coy DH; Taylor JE; Moreau JP; Yasuda K; Bell GI; Reisine T
Mol Pharmacol; 1993 Jun; 43(6):838-44. PubMed ID: 8100350
[TBL] [Abstract][Full Text] [Related]
12. 17 beta-estradiol induces somatostatin (SRIF) inhibition of prolactin release and regulates SRIF receptors in rat anterior pituitary cells.
Kimura N; Hayafuji C; Konagaya H; Takahashi K
Endocrinology; 1986 Sep; 119(3):1028-36. PubMed ID: 2874016
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a biotinylated somatostatin analog as a receptor probe.
Schonbrunn A; Lee AB; Brown PJ
Endocrinology; 1993 Jan; 132(1):146-54. PubMed ID: 8093437
[TBL] [Abstract][Full Text] [Related]
14. The somatostatin receptor is directly coupled to adenylate cyclase in GH4C1 pituitary cell membranes.
Koch BD; Schonbrunn A
Endocrinology; 1984 May; 114(5):1784-90. PubMed ID: 6143660
[TBL] [Abstract][Full Text] [Related]
15. Somatostatin receptors on rat anterior pituitary membranes.
Enjalbert A; Tapia-Arancibia L; Rieutort M; Brazeau P; Kordon C; Epelbaum J
Endocrinology; 1982 May; 110(5):1634-40. PubMed ID: 6122557
[TBL] [Abstract][Full Text] [Related]
16. Differential involvement of signaling pathways in the regulation of growth hormone release by somatostatin and growth hormone-releasing hormone in orange-spotted grouper (Epinephelus coioides).
Wang B; Qin C; Zhang C; Jia J; Sun C; Li W
Mol Cell Endocrinol; 2014 Feb; 382(2):851-9. PubMed ID: 24183819
[TBL] [Abstract][Full Text] [Related]
17. Modulation of somatostatin binding to rat pituitary membranes by exogenously administered growth hormone.
Katakami H; Berelowitz M; Marbach M; Frohman LA
Endocrinology; 1985 Aug; 117(2):557-60. PubMed ID: 2862011
[TBL] [Abstract][Full Text] [Related]
18. Effect of 17beta-estradiol on somatostatin receptor expression and inhibitory effects on growth hormone and prolactin release in rat pituitary cell cultures.
Djordjijevic D; Zhang J; Priam M; Viollet C; Gourdji D; Kordon C; Epelbaum J
Endocrinology; 1998 May; 139(5):2272-7. PubMed ID: 9564833
[TBL] [Abstract][Full Text] [Related]
19. Somatostatin and regulation of prolactin secretion.
Enjalbert A; Bertrand P; Le Dafniet M; Epelbaum J; Hugues JN; Kordon C; Moyse E; Peillon F; Shu C
Psychoneuroendocrinology; 1986; 11(2):155-65. PubMed ID: 2875480
[TBL] [Abstract][Full Text] [Related]
20. Somatostatin receptor subtype specificity in human fetal pituitary cultures. Differential role of SSTR2 and SSTR5 for growth hormone, thyroid-stimulating hormone, and prolactin regulation.
Shimon I; Taylor JE; Dong JZ; Bitonte RA; Kim S; Morgan B; Coy DH; Culler MD; Melmed S
J Clin Invest; 1997 Feb; 99(4):789-98. PubMed ID: 9045884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
